Carregando...

Long-term post-mortem studies following neurturin gene therapy in patients with advanced Parkinson’s disease

We performed post-mortem studies on two patients with advanced Parkinson’s disease 8 and10 years following AAV2-neurturin (CERE120) gene therapy, the longest post-mortem trophic factor gene therapy cases reported to date. CERE120 was delivered to the putamen bilaterally in one case (10 years post-su...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Brain
Principais autores: Chu, Yaping, Bartus, Raymond T, Manfredsson, Fredric P, Olanow, C Warren, Kordower, Jeffrey H
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7089653/
https://ncbi.nlm.nih.gov/pubmed/32203581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/brain/awaa020
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!